[Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Rhea-AI Filing Summary

Parameswaran Prabha, Vice Chair and officer of Colgate-Palmolive Company (CL), reported equity awards granted on 09/11/2025. The filing shows a grant of 4,592 restricted stock units (RSUs) that vest in three equal annual installments starting one year after grant and a stock option award covering 31,796 shares with an exercise price of $84.06, exercisable in equal annual installments over three years and expiring 09/11/2033. After the RSU grant, Mr. Prabha directly beneficially owns 12,696 shares. The filing also reports 5,955 shares held indirectly by the issuer's 401(k) plan trustee and 46,810 shares held indirectly by a trust (which includes 9,980 shares previously reported).

Positive

• 4,592 restricted stock units granted with a clear vesting schedule (one‑third annually)
• 31,796 stock options granted with specified exercise price of $84.06 and expiration 09/11/2033
• Post‑transaction direct ownership disclosed: 12,696 shares, plus quantified indirect holdings via 401(k) and trust

Negative

• None.

Insights

Financial Analyst

TL;DR: Officer received time‑based equity awards: 4,592 RSUs and options for 31,796 shares at $84.06, standard compensation disclosure.

The reported awards on 09/11/2025 consist of a restricted stock unit grant that vests in three equal annual installments and a stock option grant exercisable over three years with an $84.06 exercise price and a 2033 expiration. The post‑transaction direct beneficial ownership of 12,696 shares and indirect holdings (5,955 via 401(k) trustee; 46,810 via trust) are disclosed. These are routine incentive compensation items; the filing provides clear vesting and exercisability schedules required for Section 16 reporting.

Corporate Governance Expert

TL;DR: Disclosure shows standard executive equity compensation and required insider reporting; vesting schedule and ownership are clearly stated.

The Form 4 indicates grants made under the issuer's incentive compensation plan with explicit vesting and exercisability terms: RSUs vest in equal one‑third installments annually and options vest similarly over three years. Indirect holdings via a 401(k) trustee and a trust are quantified and a prior reporting correction is noted (9,980 shares previously reported as direct). Signature and attorney‑in‑fact details complete the compliance filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parameswaran Prabha

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chair

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		A(1)		4,592	A	$0.0000	12,696	D
Common Stock								5,955	I	By Issuer's 401(k) Plan Trustee
Common Stock								46,810(2)	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$84.06	09/11/2025		A(3)		31,796		(4)	09/11/2033	Common Stock	31,796	$0.0000	31,796	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. This amount includes 9,980 shares that were previously reported as directly beneficially owned.

3. Stock option award granted under the issuer's incentive compensation plan.

4. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Parameswaran Prabha receive on 09/11/2025 for CL?

The Form 4 reports a grant of 4,592 restricted stock units and a stock option covering 31,796 shares with an exercise price of $84.06.

When do the RSUs and options vest and when do the options expire?

The RSUs vest in equal one‑third installments on each of the first, second and third anniversaries of the grant date. The options vest in equal annual installments over three years beginning on the first anniversary and expire on 09/11/2033.

How many shares does Mr. Prabha beneficially own after the reported transaction?

Following the reported transaction, Mr. Prabha directly beneficially owns 12,696 shares. Indirect holdings include 5,955 shares via the issuer's 401(k) plan trustee and 46,810 shares via a trust.

What is the relationship of the reporting person to Colgate‑Palmolive (CL)?

The filing identifies Parameswaran Prabha as Vice Chair and an officer of the issuer.

Does the filing indicate any previously reported holdings?

Yes. The trust holdings of 46,810 shares include 9,980 shares that were previously reported as directly beneficially owned.